Please login to the form below

Not currently logged in
Email:
Password:

companion diagnostics

This page shows the latest companion diagnostics news and features for those working in and with pharma, biotech and healthcare.

Lynparza could soon add first line ovarian use in Europe

Lynparza could soon add first line ovarian use in Europe

As with other ‘personalised medicine’ drugs, the company’s commercial division is aiming to maximise uptake by broadening access to companion diagnostics which can identify BRCA mutations in patients across these

Latest news

More from news
Approximately 3 fully matching, plus 29 partially matching documents found.

Latest Intelligence

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    9. RUTH MARCH. Precision medicine leader. Precision medicine and the use of companion diagnostics now plays a fully integrated role in many successful new cancer therapies. ... But how do you deliver these companion diagnostics to healthcare systems and

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    This encompasses approaches to detecting cancers earlier, including novel techniques such as liquid biopsies (aka circulating tumour DNA tests) and new companion diagnostics.

  • Breakthrough innovation Breakthrough innovation

    The same key agile principles with a different twist. Many pharmaceutical companies are increasingly looking to innovate through the development of companion diagnostics and drug delivery devices, and/or services such ... An optimal innovation approach.

  • Choosing destiny Choosing destiny

    immuno-oncology and companion diagnostics.

  • Harnessing complexity Harnessing complexity

    Companion diagnostics in oncology. As an increasing number of drugs gain approval for patients whose cancers have certain molecular characteristics, the promise of truly personalised medicine is edging closer towards reality. ... This delicate balance

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

  • Dr Holger Adelmann joins DIA EMEA Dr Holger Adelmann joins DIA EMEA

    In that role he oversaw the reengineering of its clinical biomarker and companion diagnostics business to align with upcoming portfolio demands.

  • FlowMetric Diagnostics names president FlowMetric Diagnostics names president

    FlowMetric Diagnostics, a provider of flow cytometry and cell sorting services, has appointed Amy Williams as its president. ... It is a great time for the development of new flow cytometry-based companion diagnostics which can help advance personalised

  • Roche appoints new oncology research head Roche appoints new oncology research head

    Commenting on Pao's appointment, Reed said: "William is recognised as one of the world's leading molecular oncologists, with world class expertise in targeted cancer therapeutics, translational medicine, molecular diagnostics, ... diagnostics company,

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Mastering the precision medicine opportunity

    Novartis and Roche are two champions of personalised medicine, shaping the area with the launch of targeted treatments combined with a companion diagnostic to support patient identification. ... approval of their new  FoundationOne CDx, the first and

  • Excellence in oncology: Developing an effective biomarker strategy

    Biomarkers and companion diagnostics offer incredibly valuable predictive power, which is of benefit to payers, physicians and patients.

  • Research Partnership

    Medical devices and diagnostics. Our experience covers everything from insulin pens to large-scale surgical systems. ... Biomarkers and companion diagnostics offer incredibly valuable predictive power, which is of benefit to payers, physicians and

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics